FindTrial
Sign In

comparison of drug and placebo for post operative pain relief in patients undergoing uterus removal surgery under spinal anaesthesia

Comparison of Gabapentin and placebo as pre-emptive analgesic agent for post-operative analgesia in patients undergoing elective abdominal hysterectomy under spinal anaesthesia: prospective single blind randomised controlled trial"

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/08/035563
Enrollment
60
Registered
2021-08-10
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N92- Excessive, frequent and irregularmenstruation Health Condition 2: D25- Leiomyoma of uterus Health Condition 3: O- Medical and Surgical Health Condition 4: N93- Other abnormal uterine and vaginalbleeding

Interventions

Intervention1: GABAPENTIN: TABLET GABAPENTIN 600MG PER ORAL SINGLE DOSE Control Intervention1: PLACEBO: TABLET VITAMIN C 500MG PER ORAL SINGLE DOSE

Sponsors

GOVERNMENT MEDICAL COLLEGE BHAVNAGAR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective abdominal hysterectomy 2. Patients with ASA Grade I/II

Exclusion criteria

Exclusion criteria: 1. Patient in whom spinal anaesthesia is contraindicated (i.e. Altered coagulation profile, Any spinal deformity) 2. Patients in whom Gabapentin is contraindicated (i.e. allergic to gabapentin and Patients with history of vertigo, liver & kidney disease) 3. Chronic pain syndromes 4. Patients with recent analgesic use

Design outcomes

Primary

MeasureTime frame
TO COMPARE THE POST OPERATIVE ANALGESIA AND LEVEL OF SEDATION CAUSED BY GABAPENTIN & PLACEBOTimepoint: 24 HOURS—

Secondary

MeasureTime frame
TO COMPARE BETWEEN 2 GROUPS 1. HEMODYNAMIC PARAMETERS 2. DIZZINESS AS SIDE EFFECT 3. POST OPERATIVE NAUSEA AND VOMITINGTimepoint: 24 HOURS—

Countries

India

Contacts

Public ContactDR DIVYANG SUTARIA

GOVERNMENT MEDICAL COLLEGE, BHAVNAGAR

dr.chandrika62@gmail.com9998994194

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026